 The two drug-discovery projects for novel, next generation, innovative, patentable psychedelic compounds, are expected to expand Clearminds IP portfolio Tel Aviv, Israel Vancouver, Canada, Jan. 19, 2023 GLOBE NEWSWIRE Clearmind Medicine Inc. Nasdaq, CSE: CMND, FSE: CWY Clearmind or the Company, a biotech company focused on discovery and development of novel psychedelic-derived therapeutics... The post Israel-Based Clearmind Successfully Completed Two RD Projects With The Hebrew U... 